 - To determine the efficacy and CNS-related toxicity acute and long-term of the HR regimen in which a subset of HR patients B-lineage, CNS-1 or CNS-2, WBC 100,000m3 are treated with intensive intrathecal chemotherapy and the remainder are treated with 12 Gy cranial radiation with intrathecal chemotherapy 